Esatenolol is a beta blocker.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Esatenolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Esatenolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Esatenolol. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Esatenolol. |
| Amifostine | Esatenolol may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Esatenolol. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Esatenolol. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Esatenolol. |
| Obinutuzumab | Esatenolol may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Esatenolol. |
| Rituximab | Esatenolol may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Esatenolol. |
| Zolmitriptan | Zolmitriptan may decrease the antihypertensive activities of Esatenolol. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Esatenolol. |
| Atropine | Atropine may decrease the antihypertensive activities of Esatenolol. |
| Sumatriptan | Sumatriptan may decrease the antihypertensive activities of Esatenolol. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Esatenolol. |
| Naratriptan | Naratriptan may decrease the antihypertensive activities of Esatenolol. |
| Rizatriptan | Rizatriptan may decrease the antihypertensive activities of Esatenolol. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Esatenolol. |
| Frovatriptan | Frovatriptan may decrease the antihypertensive activities of Esatenolol. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Esatenolol. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Esatenolol. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Esatenolol. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Esatenolol. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Esatenolol. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Esatenolol. |
| Amineptine | Amineptine may decrease the antihypertensive activities of Esatenolol. |
| Flibanserin | Flibanserin may decrease the antihypertensive activities of Esatenolol. |
| Naluzotan | Naluzotan may decrease the antihypertensive activities of Esatenolol. |
| Nitrous oxide | Nitrous oxide may decrease the antihypertensive activities of Esatenolol. |
| Cinitapride | Cinitapride may decrease the antihypertensive activities of Esatenolol. |
| Lurasidone | Lurasidone may decrease the antihypertensive activities of Esatenolol. |
| Tyramine | Tyramine may decrease the antihypertensive activities of Esatenolol. |
| Ifenprodil | Ifenprodil may decrease the antihypertensive activities of Esatenolol. |
| Dimetacrine | Dimetacrine may decrease the antihypertensive activities of Esatenolol. |
| Butriptyline | Butriptyline may decrease the antihypertensive activities of Esatenolol. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Esatenolol. |
| Tianeptine | Tianeptine may decrease the antihypertensive activities of Esatenolol. |
| Oxaprotiline | Oxaprotiline may decrease the antihypertensive activities of Esatenolol. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Esatenolol. |
| Tetrahydrocannabivarin | Tetrahydrocannabivarin may decrease the antihypertensive activities of Esatenolol. |
| Piclozotan | Piclozotan may decrease the antihypertensive activities of Esatenolol. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Esatenolol. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Esatenolol. |
| Tramazoline | Tramazoline may decrease the antihypertensive activities of Esatenolol. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the antihypertensive activities of Esatenolol. |
| Dibenzepin | Dibenzepin may decrease the antihypertensive activities of Esatenolol. |
| Quinupramine | Quinupramine may decrease the antihypertensive activities of Esatenolol. |
| Trichloroethylene | Trichloroethylene may decrease the antihypertensive activities of Esatenolol. |
| Fenozolone | Fenozolone may decrease the antihypertensive activities of Esatenolol. |
| Melitracen | Melitracen may decrease the antihypertensive activities of Esatenolol. |
| Lofepramine | Lofepramine may decrease the antihypertensive activities of Esatenolol. |
| Xenon | Xenon may decrease the antihypertensive activities of Esatenolol. |
| Iprindole | Iprindole may decrease the antihypertensive activities of Esatenolol. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Esatenolol. |
| Diethyl ether | Diethyl ether may decrease the antihypertensive activities of Esatenolol. |
| Imipramine oxide | Imipramine oxide may decrease the antihypertensive activities of Esatenolol. |
| Mefenorex | Mefenorex may decrease the antihypertensive activities of Esatenolol. |
| 5-methoxy-N,N-dimethyltryptamine | 5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Esatenolol. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Esatenolol. |
| Solriamfetol | Solriamfetol may decrease the antihypertensive activities of Esatenolol. |
| Sufentanil | Sufentanil may decrease the antihypertensive activities of Esatenolol. |
| Isoflurane | Isoflurane may decrease the antihypertensive activities of Esatenolol. |
| Propofol | Propofol may decrease the antihypertensive activities of Esatenolol. |
| Remifentanil | Remifentanil may decrease the antihypertensive activities of Esatenolol. |
| Halothane | Halothane may decrease the antihypertensive activities of Esatenolol. |
| Desflurane | Desflurane may decrease the antihypertensive activities of Esatenolol. |
| Sevoflurane | Sevoflurane may decrease the antihypertensive activities of Esatenolol. |
| Protriptyline | Protriptyline may decrease the antihypertensive activities of Esatenolol. |
| Opipramol | Opipramol may decrease the antihypertensive activities of Esatenolol. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Esatenolol. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Esatenolol. |
| Cannabidiol | The metabolism of Esatenolol can be decreased when combined with Cannabidiol. |
| Amiodarone | The therapeutic efficacy of Esatenolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Esatenolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Esatenolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Esatenolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Esatenolol. |
| Fingolimod | Esatenolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Esatenolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Esatenolol. |
| Methacholine | Esatenolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Esatenolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Esatenolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Esatenolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Esatenolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Esatenolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Esatenolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Esatenolol. |
| Rivastigmine | Esatenolol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Esatenolol can be increased when it is combined with Mirabegron. |
| Molsidomine | Molsidomine may increase the hypotensive activities of Esatenolol. |
| Insulin argine | Esatenolol may increase the hypoglycemic activities of Insulin argine. |
| Remikiren | Remikiren may increase the hypotensive activities of Esatenolol. |
| Guanadrel | Guanadrel may increase the hypotensive activities of Esatenolol. |
| Carteolol | Carteolol may increase the hypotensive activities of Esatenolol. |
| Bosentan | Bosentan may increase the hypotensive activities of Esatenolol. |
| Candoxatril | Candoxatril may increase the hypotensive activities of Esatenolol. |
| Metyrosine | Metyrosine may increase the hypotensive activities of Esatenolol. |